-+ 0.00%
-+ 0.00%
-+ 0.00%

Earnings Summary: Entrada Therapeutics Q4

Benzinga·02/26/2026 12:26:13
Listen to the news

The earnings results for Entrada Therapeutics (NASDAQ:TRDA) for Q4 were made public on Thursday, February 26, 2026 at 07:00 AM.

Here's a comprehensive overview of the announcement.

Earnings

Entrada Therapeutics beat estimated earnings by 22.95%, reporting an EPS of $-0.94 versus an estimate of $-1.22.

Revenue was down $36.10 million from the same period last year.

Historical Earnings Summary

Last quarter the company missed on EPS by $0.07 which was followed by a 0.58% drop in the share price the next day.

Here's a look at Entrada Therapeutics's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.99 -0.86 -0.72 -0.66
EPS Actual -1.06 -1.04 -0.42 0.03
Revenue Estimate 7.32M 8.45M 11.95M 12.92M
Revenue Actual 1.61M 1.95M 20.56M 37.40M

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Entrada Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.